Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
After finishing at $5.96 in the prior trading day, Amicus Therapeutics Inc (NASDAQ: FOLD) closed at $6.05, up 1.51%. In other words, the price has increased by $1.51 from its previous closing price. On the day, 3.63 million shares were traded. FOLD stock price reached its highest trading level at $6.115 during the session, while it also had its lowest trading level at $5.95.
Ratios:
Our goal is to gain a better understanding of FOLD by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 7.43 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 1157.13. For the most recent quarter (mrq), Quick Ratio is recorded 2.47 and its Current Ratio is at 3.34. In the meantime, Its Debt-to-Equity ratio is 2.29 whereas as Long-Term Debt/Eq ratio is at 2.25.
On December 13, 2024, Morgan Stanley Downgraded its rating to Equal-Weight which previously was Overweight and also lowered its target price recommendation from $17 to $12.
On September 06, 2024, Jefferies started tracking the stock assigning a Buy rating and target price of $18.Jefferies initiated its Buy rating on September 06, 2024, with a $18 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Feb 19 ’25 when Campbell Bradley L sold 400 shares for $10.00 per share. The transaction valued at 4,000 led to the insider holds 1,150,657 shares of the business.
BRADLEY CAMPBELL bought 400 shares of FOLD for $3,940 on Feb 19 ’25. On Dec 02 ’24, another insider, Campbell Bradley L, who serves as the President and CEO of the company, sold 7,500 shares for $10.02 each. As a result, the insider received 75,124 and left with 886,654 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, FOLD now has a Market Capitalization of 1862982656 and an Enterprise Value of 1957337600. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.43 while its Price-to-Book (P/B) ratio in mrq is 9.62. Its current Enterprise Value per Revenue stands at 3.604 whereas that against EBITDA is 34.941.
Stock Price History:
The Beta on a monthly basis for FOLD is 0.53, which has changed by -0.4202335 over the last 52 weeks, in comparison to a change of 0.13161862 over the same period for the S&P500. Over the past 52 weeks, FOLD has reached a high of $12.65, while it has fallen to a 52-week low of $5.51. The 50-Day Moving Average of the stock is -0.25%, while the 200-Day Moving Average is calculated to be -29.08%.
Shares Statistics:
The stock has traded on average 5.06M shares per day over the past 3-months and 4097640 shares per day over the last 10 days, according to various share statistics. A total of 307.92M shares are outstanding, with a floating share count of 297.12M. Insiders hold about 3.51% of the company’s shares, while institutions hold 100.78% stake in the company. Shares short for FOLD as of 1749772800 were 20898939 with a Short Ratio of 4.20, compared to 1747267200 on 20180243. Therefore, it implies a Short% of Shares Outstanding of 20898939 and a Short% of Float of 6.83.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
